Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Aug;54(2):311–317. doi: 10.1038/bjc.1986.178

Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study.

C La Vecchia, A Decarli, M Fasoli, S Franceschi, A Gentile, E Negri, F Parazzini, G Tognoni
PMCID: PMC2001528  PMID: 3741766

Abstract

We analysed data from a case-control investigation conducted in Milan, Northern Italy, to evaluate the relation between the use of combination oral contraceptives and the risk of cancers of the breast, ovary, endometrium and cervix uteri. For the present analysis, 776 cases of histologically confirmed breast cancer, 406 of epithelial ovarian cancer and 170 of endometrial cancer aged under 60 were compared with a group of 1,282 subjects below age 60 admitted for a spectrum of acute conditions apparently unrelated to oral contraceptive use or to any of the known or potential risk factors for the diseases under study. Likewise, 225 cases of invasive cervical cancer were compared with 225 age-matched inpatient controls, and 202 cases of cervical intra-epithelial neoplasia with 202 outpatient controls identified in the same screening clinics. The age-adjusted relative risk estimates for ever vs. never use of combination oral contraceptives were 1.04 (95% confidence interval (CI) 0.73-1.37) for breast cancer, 0.68 (95% CI = 0.48-0.97) for epithelial ovarian cancer, 0.50 (95% CI = 0.23-1.12) for endometrial cancer, 1.49 (95% CI = 0.88-2.55) for cervical cancer and 0.77 (95% CI = 0.50-1.18) for cervical intra-epithelial neoplasia. The risk of ovarian cancer decreased and that of invasive cervical cancer increased with longer duration of use. Neither duration of oral contraceptive use nor time since first or last use significantly altered a user's risk of other neoplasms considered. Likewise, analysis of sub-groups of age, parity or other potentially important covariates did not show any important interaction, and allowance for them by means of logistic regression did not materially modify any of the results. These data confirm that combination oral contraceptives confer some protection against ovarian and endometrial cancers but may increase the risk of invasive cervical cancer if used for several years, and indicate that the past or current pattern of oral contraceptive use in Italy is unlikely materially to affect the risk of breast cancer.

Full text

PDF
311

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyce J. G., Lu T., Nelson J. H., Jr, Fruchter R. G. Oral contraceptives and cervical carcinoma. Am J Obstet Gynecol. 1977 Aug 1;128(7):761–766. doi: 10.1016/0002-9378(77)90717-7. [DOI] [PubMed] [Google Scholar]
  2. Brinton L. A., Hoover R., Szklo M., Fraumeni J. F., Jr Oral contraceptives and breast cancer. Int J Epidemiol. 1982 Dec;11(4):316–322. doi: 10.1093/ije/11.4.316. [DOI] [PubMed] [Google Scholar]
  3. Fasal E., Paffenbarger R. S., Jr Oral contraceptives as related to cancer and benign lesions of the breast. J Natl Cancer Inst. 1975 Oct;55(4):767–773. doi: 10.1093/jnci/55.4.767. [DOI] [PubMed] [Google Scholar]
  4. Franceschi S., La Vecchia C., Talamini R. Oral contraceptives and cervical neoplasia: pooled information from retrospective and prospective epidemiologic studies. Tumori. 1986 Feb 28;72(1):21–30. doi: 10.1177/030089168607200104. [DOI] [PubMed] [Google Scholar]
  5. Harris R. W., Brinton L. A., Cowdell R. H., Skegg D. C., Smith P. G., Vessey M. P., Doll R. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer. 1980 Sep;42(3):359–369. doi: 10.1038/bjc.1980.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Janerich D. T., Polednak A. P., Glebatis D. M., Lawrence C. E. Breast cancer and oral contraceptive use: a case-control study. J Chronic Dis. 1983;36(9):639–646. doi: 10.1016/0021-9681(83)90080-2. [DOI] [PubMed] [Google Scholar]
  7. Kaufman D. W., Shapiro S., Slone D., Rosenberg L., Miettinen O. S., Stolley P. D., Knapp R. C., Leavitt T., Jr, Watring W. G., Rosenshein N. B. Decreased risk of endometrial cancer among oral-contraceptive users. N Engl J Med. 1980 Oct 30;303(18):1045–1047. doi: 10.1056/NEJM198010303031807. [DOI] [PubMed] [Google Scholar]
  8. La Vecchia C., Franceschi S., Decarli A., Fasoli M., Gentile A., Tognoni G. "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet. 1984 Oct 6;2(8406):779–782. doi: 10.1016/s0140-6736(84)90705-0. [DOI] [PubMed] [Google Scholar]
  9. La Vecchia C., Franceschi S., Decarli A., Gallus G., Tognoni G. Risk factors for endometrial cancer at different ages. J Natl Cancer Inst. 1984 Sep;73(3):667–671. [PubMed] [Google Scholar]
  10. La Vecchia C., Franceschi S., Decarli A. Oral contraceptive use and the risk of epithelial ovarian cancer. Br J Cancer. 1984 Jul;50(1):31–34. doi: 10.1038/bjc.1984.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  12. McPherson K., Neil A., Vessey M. P., Doll R. Oral contraceptives and breast cancer. Lancet. 1983 Dec 17;2(8364):1414–1415. doi: 10.1016/s0140-6736(83)90936-4. [DOI] [PubMed] [Google Scholar]
  13. Newhouse M. L., Pearson R. M., Fullerton J. M., Boesen E. A., Shannon H. S. A case control study of carcinoma of the ovary. Br J Prev Soc Med. 1977 Sep;31(3):148–153. doi: 10.1136/jech.31.3.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pike M. C., Henderson B. E., Casagrande J. T., Rosario I., Gray G. E. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer. 1981 Jan;43(1):72–76. doi: 10.1038/bjc.1981.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]
  16. Rosenberg L., Miller D. R., Kaufman D. W., Helmrich S. P., Stolley P. D., Schottenfeld D., Shapiro S. Breast cancer and oral contraceptive use. Am J Epidemiol. 1984 Feb;119(2):167–176. doi: 10.1093/oxfordjournals.aje.a113735. [DOI] [PubMed] [Google Scholar]
  17. Rosenberg L., Shapiro S., Slone D., Kaufman D. W., Helmrich S. P., Miettinen O. S., Stolley P. D., Rosenshein N. B., Schottenfeld D., Engle R. L., Jr Epithelial ovarian cancer and combination oral contraceptives. JAMA. 1982 Jun 18;247(23):3210–3212. [PubMed] [Google Scholar]
  18. Stadel B. V., Rubin G. L., Webster L. A., Schlesselman J. J., Wingo P. A. Oral contraceptives and breast cancer in young women. Lancet. 1985 Nov 2;2(8462):970–973. doi: 10.1016/s0140-6736(85)90524-0. [DOI] [PubMed] [Google Scholar]
  19. Thomas D. B. Relationship of oral contraceptives to cervical carcinogenesis. Obstet Gynecol. 1972 Oct;40(4):508–518. [PubMed] [Google Scholar]
  20. Vessey M., Baron J., Doll R., McPherson K., Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer. 1983 Apr;47(4):455–462. doi: 10.1038/bjc.1983.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Weiss N. S., Lyon J. L., Liff J. M., Vollmer W. M., Daling J. R. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer. 1981 Dec;28(6):669–671. doi: 10.1002/ijc.2910280602. [DOI] [PubMed] [Google Scholar]
  22. Worth A. J., Boyes D. A. A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix. J Obstet Gynaecol Br Commonw. 1972 Aug;79(8):673–679. doi: 10.1111/j.1471-0528.1972.tb12899.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES